Koichi S Kobayashi Selected Research

Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)

11/2011

Receptor-interacting protein 2 controls pulmonary host defense to Escherichia coli infection via the regulation of interleukin-17A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi S Kobayashi Research Topics

Disease

11	Neoplasms (Cancer) 03/2024 - 06/2009
11	Infections 03/2024 - 11/2008
5	Inflammation (Inflammations) 01/2022 - 08/2010
2	Escherichia coli Infections 07/2023 - 11/2011
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2013
2	Pneumonia (Pneumonitis) 01/2015 - 09/2012
2	Septic Shock (Toxic Shock Syndrome) 11/2012 - 07/2009
2	Crohn Disease (Crohn's Disease) 04/2012 - 02/2005
2	Colitis 01/2011 - 10/2010
1	Brucellosis (Malta Fever) 03/2024
1	Virus Diseases (Viral Diseases) 03/2024
1	Arthritis (Polyarthritis) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Asthma (Bronchial Asthma) 01/2018
1	Mycoses (Diseases, Fungus) 05/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2015
1	Haemophilus Infections 01/2015
1	Atrophy 02/2014
1	Colitis-Associated Neoplasms 05/2013
1	Carcinogenesis 05/2013
1	Dysbiosis 04/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2013
1	Gram-Negative Bacterial Infections 11/2012
1	Pneumococcal Pneumonia 06/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011
1	Chagas Disease (American Trypanosomiasis) 02/2010
1	Reperfusion Injury 07/2009
1	Myocardial Infarction 05/2008
1	Ischemia 05/2008
1	Anthrax 01/2008
1	Legionnaires' Disease (Legionnaire's Disease) 03/2006
1	Hyperthermia 03/2004
1	Muscle Weakness 08/2003
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2003
1	Dermatomyositis (Dermatopolymyositis) 08/2003

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2022 - 03/2004
9	Proteins (Proteins, Gene)FDA Link 03/2024 - 02/2005
6	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2015 - 10/2010
5	Interleukin-1 Receptor-Associated KinasesIBA 05/2013 - 10/2010
4	NucleotidesIBA 01/2017 - 02/2010
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2016
3	Trans-Activators (Trans-Acting Factor)IBA 01/2021 - 05/2016
3	Phosphotransferases (Kinase)IBA 01/2018 - 05/2008
3	NLR ProteinsIBA 04/2013 - 11/2011
3	LipopolysaccharidesIBA 11/2012 - 07/2009
2	Histocompatibility Antigens Class IIBA 03/2024 - 05/2016
2	Interleukin-17 (Interleukin 17)IBA 07/2023 - 11/2011
2	AntigensIBA 01/2021 - 08/2010
1	Staphylococcal Protein A (Protein A)IBA 03/2024
1	dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA 03/2024
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 03/2024
1	Carcinoembryonic AntigenIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 01/2018
1	Interleukin-33IBA 01/2018
1	cis-trans-IsomerasesIBA 01/2018
1	GlucocorticoidsIBA 01/2015
1	Etanercept (Enbrel)FDA Link 02/2014
1	DNA (Deoxyribonucleic Acid)IBA 02/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2013
1	CarcinogensIBA 05/2013
1	Dextrans (Dextran)FDA Link 05/2013
1	AzoxymethaneIBA 05/2013
1	GlucuronidaseIBA 05/2013
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2013
1	Leucine (L-Leucine)FDA Link 04/2013
1	LigandsIBA 11/2012
1	ChemokinesIBA 09/2012
1	Messenger RNA (mRNA)IBA 09/2012
1	InflammasomesIBA 01/2012
1	Cysteine Proteases (Cysteine Protease)IBA 01/2012
1	Interleukin-6 (Interleukin 6)IBA 11/2011
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011
1	Chemokine CXCL2IBA 11/2011
1	Interleukin-23 (Interleukin 23)IBA 11/2011
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2011
1	Mitogen-Activated Protein KinasesIBA 11/2011
1	Peptides (Polypeptides)IBA 09/2011
1	Acetylmuramyl-Alanyl-IsoglutamineIBA 09/2011
1	Dextran SulfateIBA 10/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2010
1	NF-kappa B (NF-kB)IBA 02/2010
1	CalciumIBA 06/2009
1	AerosolsIBA 11/2008
1	Type IV Secretion SystemsIBA 11/2008
1	Adenosine Triphosphate (ATP)IBA 05/2008
1	SB 203580IBA 05/2008
1	p38 Mitogen-Activated Protein KinasesIBA 05/2008
1	FlagellinIBA 01/2008
1	PyrinIBA 01/2008
1	Pattern Recognition ReceptorsIBA 03/2006
1	Antinuclear AntibodiesIBA 08/2003
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2003
1	Synaptotagmins (Synaptotagmin)IBA 08/2003
1	CollagenIBA 08/2003

Therapy/Procedure

5	Therapeutics 01/2022 - 10/2010
2	Immunotherapy 01/2022 - 01/2021